Apolipoprotein E: Far more than a lipid transport protein

被引:1361
作者
Mahley, RW [1 ]
Rall, SC [1 ]
机构
[1] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA
关键词
genetic polymorphism; coronary disease; Alzheimer's disease; immunology; infectious disease;
D O I
10.1146/annurev.genom.1.1.507
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
First recognized as a major determinant in lipoprotein metabolism and cardiovascular disease, apolipoprotein (apo) E has emerged as an important molecule in several biological processes not directly related to its lipid transport function, including Alzheimer's disease and cognitive function, immunoregulation, and possibly even infectious diseases. ApoE is a polymorphic protein arising from three alleles at a single gene locus. The three major isoforms, apoE4, apoE3, and apoE2, differ from one another only by single amino acid substitutions, yet these changes have profound functional consequences at both the cellular and molecular levels. ApoE3 seems to be the normal isoform in all known functions, while apoE4 and apoE2 can each be dysfunctional. Isoform (allele)-specific effects include the association of apoE2 with the genetic disorder type In: hyperlipoproteinemia and with both increased and decreased risk for atherosclerosis and the association of apoE4 with increased risk for both atherosclerosis and Alzheimer's disease, impaired cognitive function, and reduced neurite outgrowth; isoform-specific differences in cellular signaling events may also exist. Functional differences in the apoE isoforms that affect (or did affect) survival before the reproductive years probably account, at least in part, for the allele frequencies of the present day.
引用
收藏
页码:507 / 537
页数:31
相关论文
共 118 条
[1]  
AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249
[2]   Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice [J].
Arai, T ;
Rinninger, F ;
Varban, L ;
Fairchild-Huntress, V ;
Liang, CP ;
Chen, WG ;
Seo, T ;
Deckelbaum, R ;
Huszar, D ;
Tall, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) :12050-12055
[3]   STABLE EXPRESSION AND SECRETION OF APOLIPOPROTEINS E3 AND E4 IN MOUSE NEUROBLASTOMA-CELLS PRODUCES DIFFERENTIAL-EFFECTS ON NEURITE OUTGROWTH [J].
BELLOSTA, S ;
NATHAN, BP ;
ORTH, M ;
DONG, LM ;
MAHLEY, RW ;
PITAS, RE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) :27063-27071
[4]   MACROPHAGE-SPECIFIC EXPRESSION OF HUMAN APOLIPOPROTEIN-E REDUCES ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC APOLIPOPROTEIN E-NULL MICE [J].
BELLOSTA, S ;
MAHLEY, RW ;
SANAN, DA ;
MURATA, J ;
NEWLAND, DL ;
TAYLOR, JM ;
PITAS, RE .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2170-2179
[5]   Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele [J].
Bergeron, N ;
Havel, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :65-72
[6]  
BOERWINKLE E, 1991, AM J HUM GENET, V49, P1145
[7]   LIPOPROTEIN METABOLISM IN THE MACROPHAGE - IMPLICATIONS FOR CHOLESTEROL DEPOSITION IN ATHEROSCLEROSIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1983, 52 :223-261
[8]   APOLIPOPROTEIN-E (APOE), A NOVEL HEPARIN-BINDING PROTEIN INHIBITS THE DEVELOPMENT OF KAPOSIS SARCOMA-LIKE LESIONS IN BALB/C NU/NU MICE [J].
BROWNING, PJ ;
ROBERTS, DD ;
ZABRENETZKY, V ;
BRYANT, J ;
KAPLAN, M ;
WASHINGTON, RH ;
PANET, A ;
GALLO, RC ;
VOGEL, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) :1949-1954
[9]  
Buttini M, 1999, J NEUROSCI, V19, P4867
[10]   INHIBITION OF LYMPHOCYTE-PROLIFERATION BY SYNTHETIC PEPTIDES HOMOLOGOUS TO HUMAN-PLASMA APOLIPOPROTEIN-B AND APOLIPOPROTEIN-E [J].
CARDIN, AD ;
BOWLIN, TL ;
KRSTENANSKY, JL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (02) :741-745